IBBiShares Nasdaq Biotechnology ETF(Exchange Traded Fund )
XTF Rating* 8.8
Price:$278.27 8.68(3.22%)
52 Week:$197.44 - $280.07
Volume: 1,718,348
Avg Daily Volume: 1,331,182
Market Cap: $5,885,410,500 Avg Trade Size: 110 shares
Fund Turnover: 18 days 10/21/2014 4:00:00 PM
Similar ETFs to IBB: IXJ, DRGS

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2/9/2001Geography: Global  Asset Class: Equity
Primary Exchange: NASDAQ Stock MarketInvestment Philosophy: Passively ManagedCapitalization: Broad/Multi Cap
Issuer: BlackRock, Inc.Underlying Index: NASDAQ Biotechnology IndexStyle: Core or Blend
Index Provider: NASDAQ OMX Group, Inc.Index Composition: Cap-WeightedSector: Healthcare > Biotechnology

Structural Integrity
Investment Metrics
Fund Holdings
Fund Exposure
News Headlines
IBB Structural Integrity ranks in the 84th percentile (among all 1049 Equity ETFs over past 6 months).
as of 8/29/2014 Value  Rank (%)
Expense Ratio 0.48% 
 59.1%
Average Bid Ask Ratio Premium Content 
 75.7%
Tracking Error Premium Content 
 82.7%
Concentration Risk Premium Content 
 14.4%
Market Impact Premium Content 
 87.8%
Efficiency Premium Content 
 70.9%
Cap Gains Dist Premium Content 
 100%
     
as of 10/21/2014  
Avg Number of Components   (range) 121   (119-122)
Legal Structure Open-End Investment Company 
Annual Yield / SEC Yield 0.16% / -0.29%
Last Dividend PaidDate 0.05, 9/24/2014   See Distributions
Options / Futures Available Y  /  Y 
Short Interest / Days to Cover 50.1% /  8 days
Net Asset Value $5,885,199,000 
Premium (Discount) 0% 
*The XTF Rating for an ETF is based on statistical analysis of its structural integrity and investment metric giving a total range between 0 and 10 with 10 being the best. Read More.





© XTF Inc., All Rights Reserved. Disclaimer. Terms of Use. Privacy Policy. .12